Directory
>
Hakan Gunaydin
Hakan Gunaydin
Vice President - Computational Chemistry | Relay Therapeutics
Cambridge, Massachusetts, United States
Hakan Gunaydin
Summary
Hakan Gunaydin is an accomplished Vice President at Relay Therapeutics, specializing in computational chemistry and medicinal chemistry within the biotechnology sector. With a strong academic foundation, including a Ph.D. in Chemistry from UCLA, Hakan has a rich history of leadership roles, progressing from Graduate Student to Senior Director at Relay Therapeutics. His expertise spans a wide range of areas including biochemistry, biophysics, and drug discovery, showcasing his versatility and depth in the life sciences field. Hakan's ability to tackle complex computational problems has established him as a key player in advancing medicinal chemistry solutions. He is passionate about innovation in drug design and has a track record of impactful contributions to the industry. His leadership experience is complemented by a commitment to fostering collaborative research environments. Hakan's career reflects a blend of academic excellence and practical application, making him a respected figure among peers.
Hakan Gunaydin
Work Experience
Vice President - Computational Chemistry at
Relay Therapeutics
December 2023 - Present
Senior Director at
Relay Therapeutics
December 2021 - December 2023
Director at
Relay Therapeutics
July 2020 - December 2021
Principal Scientist at
Relay Therapeutics
September 2018 - July 2020
Principal Scientist at
Merck
June 2017 - September 2018
Associate Principal Scientist at
Merck
February 2014 - June 2017
Senior Scientist at
Amgen, Inc.
March 2013 - February 2014
Scientist at
Amgen, Inc.
April 2009 - March 2013
Postdoctoral Fellow at
Ucla
September 2008 - April 2009
Graduate Student at
Ucla
September 2003 - August 2008
Hakan Gunaydin
Education
University of California, Los Angeles, Ph.D.
January 2003 - January 2008
January 2001 - January 2003
January 1995 - January 2001
Frequently Asked Questions about Hakan Gunaydin
What is Hakan Gunaydin email address?
Hakan Gunaydin's primary email address is *********@relaytx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Hakan Gunaydin work for?
Hakan Gunaydin is a Vice President - Computational Chemistry at Relay Therapeutics, a company specializing in Commercial physical research.
Where Hakan Gunaydin graduated from?
Hakan Gunaydin holds a degree in Chemistry from University of California, Los Angeles.
How can I directly contact Hakan Gunaydin?
To contact Hakan Gunaydin directly, you can use the email address *********@relaytx.com. Complete contact information is available upon registration with Muraena.
Is Hakan Gunaydin an immigrant?
Yes, Hakan Gunaydin is an immigrant and currently based in United States
Who is Hakan Gunaydin?
Hakan Gunaydin is an accomplished Vice President at Relay Therapeutics, specializing in computational chemistry and medicinal chemistry within the biotechnology sector. With a strong academic foundation, including a Ph.D. in Chemistry from UCLA, Hakan has a rich history of leadership roles, progressing from Graduate Student to Senior Director at Relay Therapeutics. His expertise spans a wide range of areas including biochemistry, biophysics, and drug discovery, showcasing his versatility and depth in the life sciences field. Hakan's ability to tackle complex computational problems has established him as a key player in advancing medicinal chemistry solutions. He is passionate about innovation in drug design and has a track record of impactful contributions to the industry. His leadership experience is complemented by a commitment to fostering collaborative research environments. Hakan's career reflects a blend of academic excellence and practical application, making him a respected figure among peers.
Hakan`s contact details
*********@relaytx.com
Colleagues
Vice President Patient Safety Risk Management
Chief Corporate Development Officer
Chief Medical Officer
Senior Vice President, Head of Clinical Development
Vice President, Drug Substance Development and Manufacturing (CMC)
Vice President, R&D Portfolio Strategy & Operations
President & CEO
Vice President, Investor Relations & Communications
VP Clinical Science
Vice President, Head of Clinical Operations